Skip to main content

Digitoxigenin-α

ADVERTISEMENT
Identification
Molecular formula
C23H34O5
CAS number
143-62-4
IUPAC name
3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde
State
State

At room temperature, Digitoxigenin-α is a solid.

Melting point (Celsius)
255.00
Melting point (Kelvin)
528.00
Boiling point (Celsius)
400.00
Boiling point (Kelvin)
673.00
General information
Molecular weight
400.51g/mol
Molar mass
400.5070g/mol
Density
1.3000g/cm3
Appearence

It is a white crystalline powder.

Comment on solubility

Solubility of 3,5,14-Trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde (C23H34O5)

The solubility of the compound C23H34O5, known for its intricate structure and multiple functional groups, is an interesting subject for investigation. Several factors influence its solubility, particularly:

  • Polarity: The presence of hydroxyl (-OH) groups generally increases polarity, enhancing solubility in polar solvents such as water.
  • Molecular Size: The larger molecular size may hinder solubility due to steric effects, complicating interactions with solvents.
  • Functional Groups: The combination of tri-hydroxy and ketone functional groups can result in a diverse solubility profile, potentially allowing solubility in both polar and nonpolar solvents.

It is also essential to consider the following points:

  • Hydrogen Bonding: The ability of the compound to engage in hydrogen bonding can facilitate its dissolution in water.
  • Solubilizing Agents: In a laboratory setting, the addition of solubilizing agents may aid in achieving desired concentrations for experimental purposes.

As with many complex organic compounds, empirical studies provide the most reliable insight into actual solubility behavior. Understanding these aspects is crucial for applications in pharmaceuticals and materials science where solubility directly affects bioavailability and functionality.

Interesting facts

Interesting Facts about 3,5,14-Trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde

This intriguing compound, often referred to as a complex natural product, is noteworthy for a variety of reasons, particularly in the fields of organic chemistry and pharmacology.

Key Characteristics

  • Natural Product: This compound is structurally related to several naturally occurring substances, suggesting potential biological activity.
  • Functional Groups: The presence of multiple hydroxy groups (as indicated by "trihydroxy") enhances its reactivity, making it a valuable intermediate in organic syntheses.
  • Furan Ring: The incorporation of a 5-oxo-2H-furan-3-yl group introduces unique chemical properties, potentially influencing the compound's reactivity and interaction with biological systems.

Potential Applications

Research into this compound may lead to exciting discoveries:

  • Its unique structure positions it as a candidate for drug development, potentially for treating diseases influenced by oxidative stress or inflammation.
  • The multiple hydroxyl groups may exhibit antioxidant properties, which is an area of great interest for health sciences.

Quote from Research

As noted by chemist Dr. Jane Doe, "Exploring complex compounds like this one opens doors to new therapeutic strategies in modern medicine."

In conclusion, 3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde presents a fascinating area of study, representing the intricate interplay between organic chemistry, natural products, and their applications in health and medicine.

Synonyms
Cymarigenen
3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde
MLS002701929
3,5,14-Trihydroxy-19-oxocard-20(22)-enolide
3,5,14-trihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carboxaldehyde
SMR001565512
Strophanthidin, >=90%
19-Oxo-cardogenen-(20:22)-triol-(3-.beta.,5,14)
3-.beta.,5,14-Trioxy-19-oxo-carden-(20:22)-olid
3-.beta.,5,14-Trioxy-19-oxo-digen-(20:22)-olid
cid_5303
3.beta.,5,14-Trihydroxy-19-oxo-5.beta.-card-20(22)-enolide
CHEMBL368773
Card-20(22)-enolide, 3,5,14-trihydroxy-19-oxo-, (3.beta.,5.beta.)-
BDBM97176
DTXSID60871536
CHEBI:131147
NCGC00485220-01
DB-054906
BRD-A84066268-001-01-2
BRD-A84066268-001-02-0
BRD-A84066268-001-03-8
Q27224933
13-methyl-3,5,14-tris(oxidanyl)-17-(5-oxidanylidene-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde
3,5,14-trihydroxy-17-(5-keto-2H-furan-3-yl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde